Skip to content

Improvement of Total Knee Arthroplasty Effectiveness Using Preoperative Prehabilitation

Improvement of Total Knee Arthroplasty Effectiveness Through Preoperative Correction of Clinical and Functional Disorders Using a Multimodal Phenotype-Based Prehabilitation Approach

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07790146
Acronym
TKA-PREHAB
Enrollment
64
Registered
2026-08-27
Start date
2023-01-01
Completion date
2025-12-31
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis, Total Knee Arthroplasty

Keywords

Total knee arthroplasty, Prehabilitation, Osteoarthritis phenotype, Rehabilitation, Electromyography

Brief summary

Total knee arthroplasty (TKA) is the most effective treatment for stage III-IV knee osteoarthritis (OA). However, up to 30% of patients remain dissatisfied due to periarticular functional insufficiency, pain, and movement limitations. This study aims to improve TKA outcomes by developing and implementing a multimodal prehabilitation approach based on OA phenotypes (chronic pain, inflammatory, biomechanical) to correct clinical and functional disorders preoperatively, thereby enhancing postoperative recovery and quality of life.

Detailed description

Objectives: 1. To develop and implement a multimodal prehabilitation approach for patients undergoing TKA. 2. To create a computer program for selecting an individual prehabilitation complex based on the identified OA phenotype. 3. To compare TKA outcomes in patients with and without the prehabilitation complex. 4. To evaluate the effectiveness of the prehabilitation approach using a dedicated computer program. 5. To improve the algorithm of medical care organization for patients undergoing TKA. Study Material: A total of 64 patients with knee OA stage III-IV (Kellgren-Lawrence classification) were included. Patients were randomized into two groups: the main group (n=31) receiving the prehabilitation complex, and the control group (n=33) receiving standard preoperative care. Study Design: Single-center, prospective, open-label, randomized, controlled interventional clinical study. Inclusion Criteria: * Age 18 to 70 years * Verified knee OA stage III-IV (Kellgren-Lawrence) * Intermalleolar distance ≤ 8 cm (valgus) or intercondylar distance ≤ 8 cm (varus) * Limb shortening ≤ 2 cm * BMI \< 35 kg/m² * Barthel Index \> 65 points * No decompensation of concomitant chronic diseases * No recent physiotherapy or intra-articular injections (within 1-3 months) * Signed informed consent Exclusion Criteria: * Age \< 18 or \> 70 years * Limb shortening \> 2 cm * Previous knee surgery or trauma indicating secondary OA * BMI ≥ 35 kg/m² * Decompensated chronic infectious or non-infectious diseases * Inability to comply with the follow-up schedule Methods: Clinical and functional assessment was performed 4 weeks and 72 hours before surgery, and 72 hours, 4 weeks, and 12 weeks after surgery. Assessment tools included WOMAC, KOOS, VAS, HSS-KRES questionnaires, surface electromyography (EMG) of thigh and calf muscles, Two Minute Walking Test (2MWT), and Timed Up and Go (TUG) test. Statistical analysis was performed using IBM SPSS Statistics 25. Scientific Novelty: A new multimodal prehabilitation approach based on OA phenotyping was developed and patented (RF Patent No. 2844621). Two computer programs were created: one for determining the individual prehabilitation complex (RF Software Certificate No. 2026610177) and another for evaluating prehabilitation results (RF Software Certificate No. 2025662976). Expected Results: The prehabilitation complex is expected to increase the rate of favorable clinical outcomes by 2.13 times at 12 weeks post-TKA, with significant improvements in WOMAC, VAS, EMG parameters, and 2MWT distance compared to the control group.

Interventions

PROCEDUREMultimodal phenotype-based prehabilitation

A 4-week preoperative program including active/passive mechanotherapy, breathing exercises, psychological support, and phenotype-specific interventions (SMT for chronic pain, magnetotherapy for inflammation, robotic mechanotherapy for biomechanical restrictions) combined with kinesiotaping, aimed at correcting clinical and functional disorders before TKA.

Sponsors

Samara State Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Masking is not possible due to the nature of the prehabilitation and surgical procedures; both the operator and the patient are aware of the group assignment.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 to 70 years * Verified knee OA stage III-IV (Kellgren-Lawrence) * Intermalleolar distance ≤ 8 cm (valgus) or intercondylar distance ≤ 8 cm (varus) * Limb shortening ≤ 2 cm * BMI \< 35 kg/m² * Barthel Index \> 65 points * No decompensation of concomitant chronic diseases * No recent physiotherapy or intra-articular injections (within 1-3 months) * Signed informed consent

Exclusion criteria

* Age \< 18 or \> 70 years * Limb shortening \> 2 cm * Previous knee surgery or trauma indicating secondary OA * BMI ≥ 35 kg/m² * Decompensated chronic infectious or non-infectious diseases * Inability to comply with the follow-up schedule

Design outcomes

Primary

MeasureTime frameDescription
WOMAC score changeBaseline, 72 hours post-op, 4 weeks post-op, 12 weeks post-opAssessment of osteoarthritis severity and functional status using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Lower scores indicate better outcomes.
VAS pain score changeBaseline, 72 hours post-op, 4 weeks post-op, 12 weeks post-opAssessment of pain intensity using the Visual Analogue Scale (VAS), score 0-10. Lower scores indicate less pain.
m. rectus femoris action potential amplitudeBaseline, 72 hours post-op, 4 weeks post-op, 12 weeks post-opAssessment of neuromuscular control and muscle activity using surface electromyography (EMG), measured in mkV.
Two Minute Walking Test (2MWT) distanceBaseline, 72 hours post-op, 4 weeks post-op, 12 weeks post-opAssessment of functional mobility and endurance, measured in meters covered in 2 minutes.

Secondary

MeasureTime frameDescription
KOOS score changeBaseline, 72 hours post-op, 4 weeks post-op, 12 weeks post-opAssessment of knee injury and osteoarthritis outcome across multiple domains (symptoms, pain, ADL, sport/recreation, quality of life).
Timed Up and Go (TUG) test timeBaseline, 72 hours post-op, 4 weeks post-op, 12 weeks post-opAssessment of dynamic balance and functional mobility, measured in seconds.

Countries

Russia

Contacts

PRINCIPAL_INVESTIGATORDmitry Sergeevich Kudashhev, MD, PhD, Associate Professor

Samara State Medical University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026